Medpage Today on MSN3 天
Early Promise for PI3K Inhibitor in Brain Metastases
Two-thirds of patients with PI3K-mutant brain metastases responded to the maximum tolerated dose (MTD) of the small-molecule ...
Cancer Therapy Advisor2 天
Treatment and Metastasis Patterns in Breast Cancer Patients With Brain Metastasis
A retrospective study revealed differences in metastasis patterns and treatment utilization by ethnicity among patients with breast cancer and brain metastasis.
生物通1 天
我国学者在肺癌脑转移靶向治疗耐药研究方面取得进展
在国家自然科学基金项目（批准号：82072784、82072785、82273304、82303437）等资助下，复旦大学附属华山医院毛颖教授、花玮教授和迟喻丹研究员团队在免疫逃逸参与肺癌脑转移靶向治疗耐药研究方面取得进展。研究成果以“通过CTLA4 ...
Medpage Today on MSN6 天
Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapy
Brain metastases occur in as many as 50% of patients with melanoma and are associated with an "abysmal prognosis," said ...
Medpage Today on MSN2 天
Hit and Miss for CDK4/6 Inhibitor in Recurrent Brain Cancer
Progression-free survival for 6 months (PFS6) in recurrent/progressive high-grade meningioma improved more than threefold ...
Cancer Therapy Advisor6 天
Pre-Operative FSRT May Be Preferred for Patients With Brain Metastases
Pre-operative fractionated stereotactic radiotherapy (FSRT) may produce better outcomes than post-operative FSRT in cancer patients with brain metastases.
Alpha Biopharma Received NMPA Approval For Zorifertinib Tablets (Zorifer®), The World's ...
Zorifertinib is the first drug in the world to launch a registration clinical trial specifically for advanced NSCLC with CNS metastases and achieve remarkable results. It is also the only* EGFR ...